Overview

A Study of DPK-060 to Investigate Clinical Safety and Efficacy in Patients With Acute External Otitis

Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate safety and tolerability of DPK-060 2% ear drops compared to placebo for DPK-060 ear drops in patients with acute external otitis. The secondary objectives are to evaluate clinical cure and microbiological growth following treatment with DPK-060 2% ear drops compared to placebo for DPK-060 ear drops.
Phase:
Phase 2
Details
Lead Sponsor:
DermaGen AB
Collaborator:
Pergamum AB
Treatments:
Carbamide Peroxide